Tectonic Therapeutic (TECX) Enterprise Value (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Enterprise Value data on file, last reported at -$236.9 million in Q1 2026.

• On a quarterly basis, Enterprise Value rose 22.64% year-over-year to -$236.9 million in Q1 2026; TTM through Mar 2026 was -$236.9 million, a 22.64% increase from a year earlier, with the FY2025 full-year figure at -$254.4 million, down 80.11% from the prior year.
• Enterprise Value for Q1 2026 stood at -$236.9 million, up from -$254.4 million in the prior quarter.
• Over the last five years, Enterprise Value for TECX reached as high as -$6.6 million in Q3 2023 and fell as low as -$306.2 million in Q1 2025.
• Historically, Enterprise Value has averaged -$146.2 million across 5 years, with a median of -$141.2 million in 2024.
• Across the five-year window, Enterprise Value soared 94.32% in 2023 and slumped 2305.79% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$92.8 million in 2022, then surged by 68.71% to -$29.1 million in 2023, then sank by 386.16% to -$141.2 million in 2024, then plunged by 80.11% to -$254.4 million in 2025, then increased by 6.87% to -$236.9 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$236.9 million in Q1 2026, -$254.4 million in Q4 2025, and -$269.0 million in Q3 2025.